Project Details
| Status | Active |
|---|---|
| Effective start/end date | 10/10/24 → 10/10/27 |
Funding
- CTI Clinical Trial and Consulting Services (Prot #21-HMedIdeS-25 // Prot #21-HMedIdeS-25)
- Hansa Biopharma AB (Prot #21-HMedIdeS-25 // Prot #21-HMedIdeS-25)
Prot #21-HMedIdeS-25: A Prospective, Long-Term Confirmatory Follow Up Trial in Highly Sensitized Patients Treated with Imlifidase or Standard of Care in the ConfIdeS (20-HMedIdeS-17) Trial
- Christopher, Derrick Andrew (PD/PI)
Project: Research project